Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Fexofenadine may help treat a difficult type of hair loss.